Professional:

A/Prof. Benjamin Fraser is the Organic Chemistry Task Leader and a Principal Radiochemist in NST Health at the Australian Nuclear Science and Technology Organisation. After obtaining his PhD at Monash University he worked as a drug discovery scientist at Biota Holdings, followed by post-doctoral work in United States at The Scripps Research Institute. Ben collaborates with scientists across Australia and internationally on the discovery and development of new radiopharmaceuticals.

Research:

A/Prof. Fraser’s laboratories focus on the discovery and development of new radiopharmaceuticals utilising both imaging (Fluorine-18, Gallium-68, Iodine-123) and therapeutic (Lutetium-177, Lead-212, Terbium-161 and Hg-203) radioisotopes. New radiopharmaceuticals undergo in vivo characterisation in animal models of disease in collaboration with the ANSTO biology and imaging teams.